White House denies report Trump got access to experimental weight loss drug

The White House has officially denied claims that President Donald Trump was granted access to an experimental weight loss drug from Eli Lilly, refuting a report that suggested otherwise. This denial underscores the administration's commitment to transparency amidst speculation about the president's health and access to experimental treatments. The controversy highlights the broader issue of who gets access to cutting-edge medical treatments, especially when there's a perception of special privileges for high-profile individuals.